C001 📈 Lyxor Core DAX (DR) UCITS - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0378438732 • Germany Equity
C001: German, Stocks, Index, Funds
‣ Company URL: http://www.amundi.com ‣ Domicile: Luxembourg ‣ Index Name: Morningstar Germany TME NR EUR
Additional Sources for C001 ETF
C001 ETF Overview
| Market Cap in USD | 1,112m |
| Category | Germany Equity |
| TER | 0.08% |
| IPO / Inception | 2023-12-07 |
C001 ETF Ratings
| Growth 5y | 60.3% |
| Fundamental | - |
| Dividend | 18.4% |
| Rel. Strength Industry | 1.28 |
| Analysts | - |
| Fair Price Momentum | 151.76 EUR |
| Fair Price DCF | - |
C001 Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 69.5% |
C001 Growth Ratios
| Growth Correlation 3m | 58.5% |
| Growth Correlation 12m | 87.1% |
| Growth Correlation 5y | 77.3% |
| CAGR 5y | 8.02% |
| CAGR/Mean DD 5y | 1.20 |
| Sharpe Ratio 12m | 1.16 |
| Alpha | -2.01 |
| Beta | 0.76 |
| Volatility | 13.37% |
| Current Volume | 1.3k |
| Average Volume 20d | 11.2k |
What is the price of C001 stocks?
As of January 02, 2025, the stock is trading at EUR 152.52 with a total of 1,281 shares traded.
Over the past week, the price has changed by -0.26%, over one month by -0.12%, over three months by +3.58% and over the past year by +18.20%.
As of January 02, 2025, the stock is trading at EUR 152.52 with a total of 1,281 shares traded.
Over the past week, the price has changed by -0.26%, over one month by -0.12%, over three months by +3.58% and over the past year by +18.20%.
Is Lyxor Core DAX (DR) UCITS a good stock to buy?
Yes. Based on ValueRay Analyses, Lyxor Core DAX (DR) UCITS (XETRA:C001) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 60.28 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of C001 as of January 2025 is 151.76. This means that C001 is currently overvalued and has a potential downside of -0.5%.
Yes. Based on ValueRay Analyses, Lyxor Core DAX (DR) UCITS (XETRA:C001) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 60.28 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of C001 as of January 2025 is 151.76. This means that C001 is currently overvalued and has a potential downside of -0.5%.
Is C001 a buy, sell or hold?
Lyxor Core DAX (DR) UCITS has no consensus analysts rating.
Lyxor Core DAX (DR) UCITS has no consensus analysts rating.
What are the forecast for C001 stock price target?
According to ValueRays Forecast Model, C001 Lyxor Core DAX (DR) UCITS will be worth about 167.5 in January 2026. The stock is currently trading at 152.52. This means that the stock has a potential upside of +9.82%.
According to ValueRays Forecast Model, C001 Lyxor Core DAX (DR) UCITS will be worth about 167.5 in January 2026. The stock is currently trading at 152.52. This means that the stock has a potential upside of +9.82%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 167.5 | 9.8% |